source
- Fecal microbiome transplant boosts peanut tolerance sixfold in early trialResearchers at Boston Children’s Hospital conducted a small open‑label phase 1 trial in which 15 adult participants received oral encapsulated fecal microbiome transplantation to test safety and ef…
- Novo Nordisk CFO describes roller-coaster growth and stays optimistic about CagriSema after Q2 earningsNovo Nordisk CFO Karsten Munk Knudsen talked to Fierce after the company released its second-quarter earnings, reflecting on his nine-year tenure and the firm’s volatile performance. He recalled a…